Playfair Display is a sophisticated font with tall, imposing letters. It’s ideal for titles, headlines and short blocks of copy – like a product description.
Playfair Display is a sophisticated font with tall, imposing letters. It’s ideal for titles, headlines and short blocks of copy – like a product description.
Playfair Display is a sophisticated font with tall, imposing letters. It’s ideal for titles, headlines and short blocks of copy – like a product description.
Playfair Display is a sophisticated font with tall, imposing letters. It’s ideal for titles, headlines and short blocks of copy – like a product description.
Playfair Display is a sophisticated font with tall, imposing letters. It’s ideal for titles, headlines and short blocks of copy – like a product description.
Playfair Display is a sophisticated font with tall, imposing letters. It’s ideal for titles, headlines and short blocks of copy – like a product description.

Prevention is Protection
Provide Immediate Protection With HyperRHO S/D® Immune Globulin
HyperRHO® S/D Full Dose
Safety

-
4-step virus removal and inactivation process
-
The only Rho(D) immune globulin product with FDA labeling for prion removal
-
Mercury (thimerosal) and latex free
-
Needle guards to protect against needlestick injury
HyperRHO® S/D Mini-Dose

Reliability
-
Dosing consistent with ACOG practice guidelines
Convenience
-
Low-volume fully assembled prefilled syringes
Protection
EFFECTIVE PROTECTION
HyperRHO S/D destroys Rh-Positive cells in the mother's body, prevents the mother's immune system from producing Rh-positive antibodies, and protects the baby from contracting HDN
IMMEDIATE PROTECTION
An antepartum and postpartum administration of a single dose of HyperRHO S/D to susceptible Rh-negative Women Reduces the risk of the mother developing antibodies to less than 0.1%
ADEQUATE PROTECTION
Each single dose syringe contains sufficient
Anti-Rho(D) to effectively suppress the immunizing potential of 15 mL of Rh-positive red blood cells
It is estimated that each year, nearly 1 million pregnancies are impacted by potential of Rh sensitization which may lead to hemolytic disease of the newborn (HDN). ₁,₂
Treatment, Safety, and Reliability matter to us.
CHOOSE HyperRHO® S/D as your prevention.
